1 week AbbVie (NYSE:ABBV) Given New $215.00 Price Target at Truist FinancialMarketBeat
Truist Financial raised their price objective on AbbVie from $210.00 to $215.00 and gave the stock a “buy” rating in a research note on Thursday.
AbbVie (ABBV) · NYSE · Science · Truist Financial Corp (TFC)
X